Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-04T16:37:15.893Z Has data issue: false hasContentIssue false

Psychotropic substance use among medical residents: prevalence and characteristics

Published online by Cambridge University Press:  27 August 2024

H. Ktari
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
M. Moalla*
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
N. Smaoui
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
I. Gassara
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
R. Feki
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
S. Omri
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
L. Zouari
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
M. maalej bouali
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
M. Maalej
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
J. Ben Thabet
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
N. Charfi
Affiliation:
Psychiatry C, Hedi Chaker Hospital of Sfax, Sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Psychotropic substance use among medical residents represents a critical concern due to its potential impact on patient care and practitioner well-being. This topic looks into the prevalence and characteristics of psychotropic substance use, including prescription medications and illicit drugs, among individuals pursuing medical residency. Understanding the scope of the problem and its distinctive features is essential for developing targeted interventions and support mechanisms within the medical community.

Objectives

To assess psychotropic substance use among medical residents, describe its characteristics and determine the prevalence of problematic use.

Methods

We conducted a cross-sectional and descriptive studyamong Tunisian medical residents over a three-month period (August - September 2022) using an online survey. Different specialties and levels of residency were included. An online self-questionnaire was used including a data collection form and the DAST-10 (Drug Abuse Screening Test) scale. The data was analyzed using the SPSS 20th version software

Results

Among the 80 residents in our study, 19 (23.8%) reported psychotropic substance use, and 12 (15%) reportedthat they had misused psychotropic drugs at least once in their lives (without a prescription and/or with a prescription but not following the instructions). The most commonly psychotropic drugs used were benzodiazepines, followed by amphetamines, analgesics, anesthetics, and pregabalin (28%, 16%, 12%, 12%, 12%, respectively).

Consumption was regular for 41.7% of those who reported psychotropic drugs misuse. The initiation of psychotropic use followed a desire to experiment various substances (41.7%), a medical prescription (33.3%), or their availability due to medical practice (25%). Self-medication and recreational use were the most common reasons for use (41.7% each). Furthermore, 31.6% of consumers revealed a problematic substance use as assessed by the DAST-10 scale.

Conclusions

Our study showed a concerning prevalence of psychotropic substance use among medical residents, benzodiazepines being the most prevalent. Notably, 15% acknowledged misuse and a significant proportion displayed problematic substance use. These results highlight the potential health risks and the importance of addressing this issue within the medical community.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.